Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Investigation of metabolically active probiotic Enterococcus and Corynebacterium and critical metabolites for their effect and molecular mechanisms on reducing phenotypes of Autism Spectrum Disorder (ASD) using a multi-omics approach in a mouse model
FY 2023-24
Summary
This project proposal is to determine beneficial probiotics that can reduce autism spectrum disorder symptoms. A panel of probiotic bacterial strains from Enterococcus and Corynebacterium genera will be given to mice that already have autism-like behaviors and monitored in comparison to a non-autism mice breed. In addition, retention of probiotics can be tracked through DNA sequencing of fecal or intestinal samples over time. Changes in behaviors can be monitored through mice-specific testing such as repetitive grooming behaviors (which models tic-like symptoms in autism) or anxiety like behaviors in an open field test. Specific secreted chemical compounds that these probiotics may produce could lead to novel compounds to use for treatment. Upon determining these compounds, they can be fed to autism-like mice to determine if any behavioral and/or neuroimmunological changes are seen.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
505893
Name
Cao Kevin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigation of metabolically active probiotic Enterococcus and Corynebacterium and critical metabolites for their effect and molecular mechanisms on reducing phenotypes of Autism Spectrum Disorder (ASD) using a multi-omics approach in a mouse model
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Asd; Autism Spectrum Disorder; Biochemistry; Biomedical Science; Metabolomics; Metagenomics; Molecular Biology; Neuroimmunology; Neurotransmitters; Probiotics; Proteomics
Abstract
This project proposal is to determine beneficial probiotics that can reduce autism spectrum disorder symptoms. A panel of probiotic bacterial strains from Enterococcus and Corynebacterium genera will be given to mice that already have autism-like behaviors and monitored in comparison to a non-autism mice breed. In addition, retention of probiotics can be tracked through DNA sequencing of fecal or intestinal samples over time. Changes in behaviors can be monitored through mice-specific testing such as repetitive grooming behaviors (which models tic-like symptoms in autism) or anxiety like behaviors in an open field test. Specific secreted chemical compounds that these probiotics may produce could lead to novel compounds to use for treatment. Upon determining these compounds, they can be fed to autism-like mice to determine if any behavioral and/or neuroimmunological changes are seen.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Cao, Kevin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~